These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7626848)

  • 21. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic colony-stimulating factors and dose intensity.
    Petros WP; Peters WP
    Semin Oncol; 1993 Feb; 20(1):94-9. PubMed ID: 7682727
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose chemotherapy and stem cell transplantation in solid tumors. Proceedings of a meeting. Berlin, Germany, 27-28 April 1996.
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S1-74. PubMed ID: 9053055
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale of intensive chemotherapy associated with autologous bone marrow transplantation.
    Zittoun R
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):373-82. PubMed ID: 3912916
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic intensification: contribution of G-CSF].
    Marty M; Extra JM; Giacchetti S
    Pathol Biol (Paris); 1993 Jan; 41(1):53-5. PubMed ID: 7686290
    [No Abstract]   [Full Text] [Related]  

  • 26. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
    Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
    Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?
    Aljitawi OS; McGuirk JP
    J Comp Eff Res; 2012 Jan; 1(1):57-70. PubMed ID: 24237297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Perkins JB; Effenbein GJ; Fields KK
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic drugs, collection of stem cells and hematologic recovery after autologous transplantation.
    Schmitz N
    Haematologica; 2005 Jan; 90(1):4-5. PubMed ID: 15644304
    [No Abstract]   [Full Text] [Related]  

  • 31. High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience.
    Bosly A; Haioun C; Gisselbrecht C; Reyes F; Coiffier B
    Eur J Haematol Suppl; 2001 Jul; 64():3-7. PubMed ID: 11486398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.
    Douer D; Levine A; Anderson WF; Gordon M; Groshen S; Khan A; Mohrbacher A; Muggia F; Shibata D
    Hum Gene Ther; 1996 Mar; 7(5):669-84. PubMed ID: 8845392
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.
    Williams SF; Bitran JD; Richards JM; DeChristopher PJ; Orlina AR
    Prog Clin Biol Res; 1990; 333():461-9. PubMed ID: 1968650
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose chemotherapy for malignancies: a review.
    Roman-Unfer S; Bitran JD
    Compr Ther; 1996 Feb; 22(2):107-20. PubMed ID: 8689864
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow transplantation in solid tumors.
    Goldstone AH
    Curr Opin Oncol; 1990 Apr; 2(2):269-76. PubMed ID: 2095241
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cellular therapies in 2002].
    Bregni M
    Tumori; 2002; 88(6):A20-4. PubMed ID: 12597161
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy dose escalation: case unproven.
    Siu LL; Tannock IF
    J Clin Oncol; 1997 Aug; 15(8):2765-8. PubMed ID: 9256117
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
    Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
    Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.